COVID-19 treatment: China approves human testing for potential vaccine developed by local company Chongqing Zhifei
The potential COVID-19 vaccine, co-developed by Anhui Zhifei Longcom Biopharmaceutical and the Institute of Microbiology of the Chinese Academy of Sciences, has received a certificate from the National Medical Products Administration to launch clinical trials.
Beijing: China has approved a coronavirus vaccine candidate developed by Chongqing Zhifei Biological Products’ unit to begin human testing, the company said in a filing on Tuesday.
The potential vaccine, co-developed by Anhui Zhifei Longcom Biopharmaceutical and the Institute of Microbiology of the Chinese Academy of Sciences, has received a certificate from the National Medical Products Administration to launch clinical trials.
Chinese researchers and companies are testing six experimental shots in humans, and more than a dozen vaccines are in different stages of clinical trials globally against the virus that has killed over 470,000 people.
However, none of the them have passed large-scale, late-stage phase 3 clinical trials, a necessary step before entering the consumer market.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
After his test was inconclusive, Racing Point driver Sergio Perez was retested and was awaiting the outcome.
Palermo Ladies Open: Tour-level tennis resumes after five-month hiatus with no handshakes or showers
A limited number of fans were allowed into the 1,500-seat stadium court and had to follow social distancing measures.
Just a day before the NBA restarts in a bubble in Orlando, the league announced that all 344 players have tested negative for COVID-19.